Cargando…
Adding clinical value with coronary flow assessment in hypertrophic obstructive cardiomyopathy
Autores principales: | Schindler, Thomas H., Brown, David L., Sadhu, Justin S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154312/ https://www.ncbi.nlm.nih.gov/pubmed/32310245 http://dx.doi.org/10.1016/j.ijcha.2020.100512 |
Ejemplares similares
-
Emergence of endocardium/epicardium flow gradient as novel risk biomarker in patients with hypertrophic cardiomyopathy
por: Schindler, Thomas H., et al.
Publicado: (2020) -
Pharmacological Strategies for Midventricular Obstruction in Patients with Hypertrophic Cardiomyopathy
por: Minami, Yuichiro, et al.
Publicado: (2018) -
The consolidation of surgery for hypertrophic obstructive cardiomyopathy in
Asia and the Pacific Rim
por: Quintana, Eduard, et al.
Publicado: (2021) -
Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023) -
Septal Ablation in Obstructive Hypertrophic Cardiomyopathy
(oHCM)
por: Almeida, Dirceu Rodrigues
Publicado: (2019)